Karuna Therapeutics, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported net loss was USD 433.68 million compared to USD 276.34 million a year ago. Basic loss per share from continuing operations was USD 11.73 compared to USD 8.74 a year ago.